Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1373

1.

Edoxaban -- Benefit Assessment According to ยง35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Oct 28.

2.

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes.

Ioannou A, Tsappa I, Metaxa S, Missouris CG.

Patient Relat Outcome Meas. 2017 Nov 3;8:121-131. doi: 10.2147/PROM.S117549. eCollection 2017. Review.

3.

Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.

Nishimura M, Hsu JC.

Am J Cardiol. 2017 Oct 12. pii: S0002-9149(17)31602-8. doi: 10.1016/j.amjcard.2017.09.030. [Epub ahead of print] Review.

PMID:
29132650
4.

Indications and Methods of Anticoagulation Reversal.

Holzmacher JL, Sarani B.

Surg Clin North Am. 2017 Dec;97(6):1291-1305. doi: 10.1016/j.suc.2017.07.002. Epub 2017 Oct 5. Review.

PMID:
29132510
5.

Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.

Kimachi M, Furukawa TA, Kimachi K, Goto Y, Fukuma S, Fukuhara S.

Cochrane Database Syst Rev. 2017 Nov 6;11:CD011373. doi: 10.1002/14651858.CD011373.pub2. [Epub ahead of print] Review.

PMID:
29105079
6.

Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views.

Ghadban R, Flaker G, Katta N, Alpert MA.

Hemodial Int. 2017 Oct;21 Suppl 2:S47-S56. doi: 10.1111/hdi.12600. Review.

PMID:
29064182
7.

Medical Treatment of Intracranial Atherosclerosis: An Update.

Kim JS, Bang OY.

J Stroke. 2017 Sep;19(3):261-270. doi: 10.5853/jos.2017.01830. Epub 2017 Sep 29. Review.

8.

Novel Anticoagulant Therapy of Venous Thromboembolism: Current Status and Future Directions.

Nakamura M, Yamada N, Ito M.

Ann Vasc Dis. 2017 Jun 25;10(2):92-98. doi: 10.3400/avd.ra.17-00015. Review.

9.

Prompt diagnosis of AF lowers risk of complications.

Leo M, Betts T.

Practitioner. 2016 Oct;260(1797):11-7. Review.

PMID:
29016085
10.

Navigating the anticoagulant landscape in 2017.

Douketis JD.

Cleve Clin J Med. 2017 Oct;84(10):768-778. doi: 10.3949/ccjm.84gr.17005. Review.

11.

Pediatric Hospital Acquired Venous Thromboembolism.

Witmer CM, Takemoto CM.

Front Pediatr. 2017 Sep 19;5:198. doi: 10.3389/fped.2017.00198. eCollection 2017. Review.

12.

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.

Bala MM, Celinska-Lowenhoff M, Szot W, Padjas A, Kaczmarczyk M, Swierz MJ, Undas A.

Cochrane Database Syst Rev. 2017 Oct 2;10:CD012169. doi: 10.1002/14651858.CD012169.pub2. Review.

PMID:
28968483
13.

Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.

Ueberham L, Dagres N, Potpara TS, Bollmann A, Hindricks G.

Adv Ther. 2017 Oct;34(10):2274-2294. doi: 10.1007/s12325-017-0616-6. Epub 2017 Sep 27. Review.

14.

Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation.

Estcourt LJ, Desborough MJ, Doree C, Hopewell S, Stanworth SJ.

Cochrane Database Syst Rev. 2017 Sep 25;9:CD012497. doi: 10.1002/14651858.CD012497.pub2. Review.

PMID:
28945930
15.

Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs.

Di L, Breen C, Chambers R, Eckley ST, Fricke R, Ghosh A, Harradine P, Kalvass JC, Ho S, Lee CA, Marathe P, Perkins EJ, Qian M, Tse S, Yan Z, Zamek-Gliszczynski MJ.

J Pharm Sci. 2017 Dec;106(12):3442-3452. doi: 10.1016/j.xphs.2017.09.005. Epub 2017 Sep 18. Review.

PMID:
28927987
16.

DVT Prevention in Stroke.

Goshgarian C, Gorelick PB.

Curr Neurol Neurosci Rep. 2017 Sep 18;17(10):81. doi: 10.1007/s11910-017-0782-6. Review.

PMID:
28921057
17.

Challenges of Anticoagulation Therapy in Pregnancy.

Fogerty AE.

Curr Treat Options Cardiovasc Med. 2017 Sep 14;19(10):76. doi: 10.1007/s11936-017-0575-x. Review.

PMID:
28913590
18.

Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins.

Smrke A, Gross PL.

Front Med (Lausanne). 2017 Aug 28;4:142. doi: 10.3389/fmed.2017.00142. eCollection 2017. Review.

19.

Availability of patient decision aids for stroke prevention in atrial fibrillation: A systematic review.

O'Neill ES, Grande SW, Sherman A, Elwyn G, Coylewright M.

Am Heart J. 2017 Sep;191:1-11. doi: 10.1016/j.ahj.2017.05.014. Epub 2017 Jun 3. Review.

PMID:
28888264
20.

Hand and wrist surgery without suspending warfarin or oral antiplatelet - systematic review.

Sardenberg T, Deienno FS, Miranda RF, Varanda D, Cortopassi AC, Silvares PRA.

Rev Bras Ortop. 2017 Jul 14;52(4):390-395. doi: 10.1016/j.rboe.2017.07.001. eCollection 2017 Jun-Jul. Review.

Supplemental Content

Loading ...
Support Center